extensively studied molecular aspects of bladder cancer. 9 For instances, increasing cyclin D1 positivity is regarded as a predictor of improved survival and of a lower progression rate in MIBCs. 10 Moreover, almost all MIBCs have defects in genes encoding proteins that control the G1 cell cycle checkpoint. 9 However, there is still no molecular biomarker to predict the progression of disease accurately. Therefore, it demands more efforts to explore the new molecular targets and underlying mechanism for bladder cancer, especially MIBCs.
Basic leucine zipper and W2 domains 2 (BZW2) is a member of the bZIP superfamily of transcription factors. 11 BZW2 is an evolutionary highly conserved protein and involved in cell-cell adhesion via cadherin binding. 12 BZW1, another member of the bZIP superfamily, has been recognized as a novel proliferation regulator in salivary mucoepidermoid carcinoma. 13 In contrast, there was little study reported on the potential role of BZW2 in cancers. Most recently, Cheng et al reported that BZW2 is up-regulated in osteosarcoma and its down-regulation inhibits cell growth by inactivating the Akt/mTOR signalling pathway, 11 suggesting BZW2 plays a potentially important role in osteosarcoma progression. In addition, a statistical analysis conducted on clinical patients (https:// www.proteinatlas.org/ENSG00000136261-BZW2/pathology) [14] [15] [16] showed that high expression of BZW2 is most common in urothelial cancer among a wide variety of different cancers ( Figure 1 ).
Nonetheless, it remains unclear about the exact role of BZW2 in context of MIBCs.
In the present study, we combined in vitro, in vivo, bioinformatics and clinical studies to explore the function and possible mechanism of BZW2 in MIBCs. We evaluated the expression level of BZW2 in clinical patients with advanced bladder cancer (of stage T2 and above), as well as in two different human MIBC cell lines (5637 and T24). We also assessed the effects of BZW2 knockdown on cell growth, cell cycle progression, cell death in vitro, as well as the tumour growth inhibition in vivo. The signalling pathways and disease states affected by BZW2 knockdown were further analysed, which could provide insights into the possible mechanism behind the BZW2 function in MIBCs.
| MATERIAL S AND ME THODS

| Cell line and cell culture
Human MIBC cell lines (T24 and 5637) and normal bladder epithelial cell line (SV-HUC-1) were purchased from the Cell Bank of Shanghai 
| Animals
Male BALB/c Nude mice (6-8 weeks age) were obtained from F I G U R E 1 A statistical analysis conducted on clinical patients (https://www.proteinatlas.org/ENSG00000136261-BZW2/pathology). [14] [15] [16] For each cancer, colour-coded bars indicate the percentage of patients with high and medium protein expression level. The cancer types are colour-coded according to which type of normal organ the cancer originates from. Low or not detected protein expression results in a white bar. 
| Plasmids construct and gene knockdown
The shRNA sequence corresponds to Homo sapiens basic leucine zipper and W2 domains 2 (BZW2), (GenBank accession number NM_014038). Duplex shRNA oligos were cloned into the AgeI and EcoRI sites in GV115. The sense shRNA strand of BZW2 was CCGGGCTGATGTTCTGAGCGAAGAACTCGAGTTCT TCGCTCAGAACATCAGCTTTTTG. The insert fidelity was confirmed by sequencing both strands with the following primers (forward: CCTATTTCCCATGATTCCTTCATA; reverse: GTAATA CGGTTATCCACGCG). BZW2 was knocked down with a GV115 based lentiviral vector. Lentiviruses were generated in HEK293T cells as described, 17 and then cells were infected with virus-containing supernatants. The alteration of expression of BZW2 was confirmed by real-time RT-PCR and Western blotting. 
| Cell proliferation assay
| Cell scratch test
The 5637 cells in logarithmic growth phase were treated with serum-free treatment for 24 hours, adjusted to a cell concentration of 5 × 10 5 mL −1 with RPMI-1640 medium containing 10% FBS, inoculated into 6-well plates and incubated in a 37°C, 5% CO 2 incubator. When the 5637 cells were grown to 90% confluence, the 6-well plate was removed for scratching. During the scratching process, a 10 μL tip was used to draw straight along the marking line, and the floating cells were washed away with PBS, and then the tumour cells were separately added to the medium of BZW2-knockdown (KD) group and normal control (NC) group. The incubation was continued in an incubator at 37°C in a 5% CO 2 atmosphere, after 24 hours, the degree of cell migration was observed under a fluorescence microscope. Three replicate wells were set per cell and each experiment was repeated three times.
| Cell cycle analysis
The effect of BZW2 knockdown on the cell cycle distribution was measured with PI staining according to previous publication. 
| Apoptosis assay
| Western blot analysis
Western blotting was performed as described before. 20 Briefly, cells
were harvested and lysed after treatment, next the supernatants were collected by centrifugation at 12000 rmp at 4°C. Denatured and fractionated by 12.5% SDS/PAGE, the proteins were transferred to PVDF membranes and probed with anti-BZW2 (Sigma, St. Louis, MO)
(1:300). GAPDH was used as an internal control with anti-GAPDH (Santa Cruz Biotechnology Inc, Santa Cruz, CA) (1:2000). The X-ray film was developed by an enhanced chemo-luminescence system. shown as below (Table 1) . 
| RNA isolation and quantitative real-time PCR
| Xenograft mouse model
| Statistical analysis
All experiments were performed in triplicate and the results are expressed as the mean ± SD. Data were analysed using SPSS software (Chicago, IL, USA). Differences with P-values < 0.05 were considered statistically significant.
| RE SULTS
| BZW2 is overexpressed in MIBC cell lines and MIBC tissues
Basic leucine zipper and W2 domains 2 (BZW2) has been recognized to exhibit oncogenic function in osteosarcoma. 11 With great inter- 
| BZW2 knockdown induces G1-phase cell cycle arrest and apoptosis in 5637 and T24 cells
We assessed the changes in cell cycle progression in response to BZW2 
| Microarray pathway analysis of signalling and disease states in response to BZW2 knockdown
To explore the possible molecular mechanism underlying the anticancer effects of BZW2 in MIBCs, we performed microarray pathway analysis of the signalling and disease states which might be affected by the knockdown of BZW2. From our results, a total of 609 up-regulated and 876 down-regulated genes were identified in BZW2-knockdown T24 cells compared with vector control cells.
The volcano graph demonstrates the distribution of differentially expressed genes by fold change between the KD group and the NC group ( Figure 6A ).
On the above basis, we used IPA tools (http://www.ingenuity. com) to identify differentially expressed canonical pathways by defining the enrichment P-value of the pathway. Signalling pathways associated with BZW2-knockdown cells were sequenced by theirLog(P-value) ( Figure 6B ) 23 Notably, several pathways were found to be associated with cell cycle, including cyclins and cell cycle regulation, 24 oestrogen-mediated S-phase entry, 25 G2/M DNA damage checkpoint regulation, 26 mitotic roles of PLK, 27 ATM signalling. Besides, pathways associated with cancer and apoptosis were also significantly affected, eg hereditary breast cancer signalling, IL-6 signalling, GADD45 signalling. 29, 30 Other altered pathways include hepatic fibrosis/hepatic stellate cell activation, aryl hydrocarbon receptor signalling, glucocorticoid receptor signalling, pyridoxal 5′-phosphate salvage pathway, airway pathology in chronic obstructive pulmonary disease and osteoarthritis pathway, which suggest the abnormalities in disease states and functions, eg biosynthesis. Our results were consistent with previous report that almost all MIBCs have defects in genes encoding proteins that control the G1 cell cycle checkpoint. 9 Despite the small percentage of incidences, MIBCs represent a great challenge in the clinic primarily owing to the vast majority of cancer-specific deaths compared with other cancers. Moreover, the poor prognosis as well as the aggressive characteristics made currently available treatments far from satisfied. On these bases, there is an urgent demand for the new therapeutics and novel molecular target. On the other hand, improved treatment requires detailed understanding of MIBC pathogenesis and molecular biology. In this regard, our data provided a basis for further investigation.
The in vivo studies with xenograft mice models validated our assertion that BZW2 could serve as an effective anti-cancer target against MIBCs, which was evidenced by the observations that BZW2 knockdown significantly inhibited the tumour growth. Our 
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